Results 191 to 200 of about 293,585 (262)

Add‐on treatment with vinpocetine reduces seizure frequency and improves comorbidities in patients with loss‐of‐function γ‐aminobutyric acid type A receptor variants

open access: yesEpilepsia, EarlyView.
Abstract Objective The semisynthetic compound vinpocetine has gained attention as a potential precision medicine for developmental and epileptic encephalopathies caused by loss‐of‐function (LoF) variants in γ‐aminobutyric acid type A (GABAA) receptor genes. As a positive allosteric modulator of GABAA receptors, case reports suggest that vinpocetine can
Cathrine E. Gjerulfsen   +15 more
wiley   +1 more source

Evaluating a Community-partnered Approach to Address Locally Relevant Determinants of Cancer Screening in New York City. [PDF]

open access: yesProg Community Health Partnersh
Chebli P   +17 more
europepmc   +1 more source

Epidemiology of fatal and nonfatal community firearm violence in New York City, 2019-2023. [PDF]

open access: yesInj Epidemiol
Adams LL   +4 more
europepmc   +1 more source

Nephrological perspectives on the underutilization of SGLT2is in heart failure and chronic kidney disease

open access: yes
ESC Heart Failure, Volume 12, Issue 2, Page 1490-1491, April 2025.
Özant Helvacı   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy